Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

Research Square logoLink to Research Square
[Preprint]. 2026 Jun 2:rs.3.rs-9878473. [Version 1] doi: 10.21203/rs.3.rs-9878473/v1

Reliability Assessment of Metal Quantification in Formalin-fixed, Paraffin-embedded Human Liver Tissue for Studying Liver Diseases

Nivisa Vakeesan 1, Jason Xu 2, Jamie Roberman 3,4,5, Li Tao 9, Yang Jiang 1, Amanda Vitale 7, Andrea E Cassidy-Bushrow 3,4,6, Lu Cai 2, Wanqing Liu 1,8,*
PMCID: PMC13252539  PMID: 42282032

Abstract

Formalin-fixed paraffin-embedded (FFPE) human tissues are broadly available for retrospective studies. Whether the metal levels and their interindividual variability are preserved in FFPE samples remains unclear. We aim to compare metal levels and examine their variability between paired frozen and FFPE human liver tissues. The content of 25 metals in 30 pairs of human liver tissues was quantified using Inductively Coupled Plasma Quadrupole Mass Spectrometer and compared. Three metals, cadmium (Cd), iron (Fe), and zinc (Zn) exhibited linear and rank-based correlation (Pearson coefficient >0.5). Three metals (lead (Pb), aluminum (Al), and selenium (Se)) were linearly correlated but showed weak to moderate rank-based correlation (Pb and Al Kendall’s Tau <0.3 and Se Kendall’s Tau was 0.42). Our study suggests that FFPE liver tissue can be utilized to study the impact of at least three metals (cadmium, iron, zinc) on liver diseases. Selenium had a moderate relationship and is worth investigating further.

Keywords: metal comparison, human liver tissue, formalin-fixed paraffin-embedded (FFPE), metallomics frozen samples

Introduction:

Exposure to various metals is a risk factor for chronic liver disease, e.g. steatotic liver disease (SLD), steatohepatitis, fibrosis, cirrhosis, and liver cancer. Many metals accumulate in human liver tissue, which could have detrimental or certain beneficial impacts, with many trace metals playing key roles in regular cellular and biochemical functions [1–17].

As the most common chronic liver disease, metabolic-dysfunction associated steatotic liver disease (MASLD) is manifested as a spectrum of liver histology ranging from simple steatosis to a more advanced stage, steatohepatitis (MASH), characterized by hepatic cell death, hepatocyte ballooning, lobular inflammation and fibrosis [18–22]. The pathogenesis of MASLD and MASH typically involves interaction between genetic make-up and environmental exposures [23–39]. Humans (and thus, the human liver) are exposed to various metals and trace elements in daily life; understanding how metals interact with the human genome in the development of various liver histology is critical to elucidating the disease mechanisms as well for developing new strategies for disease prevention and treatment. Indeed, numerous epidemiological studies have indicated associations between metal exposures and MASLD/MASH [40–58].

However, most published studies in humans, e.g. epidemiological analyses in this field focused on metal levels in the environment or in extrahepatic biospecimens, e.g. blood, urine, hair or nails [41, 43–46, 49, 50, 52, 53, 55, 57, 58]. The direct correlation between the hepatic level of metals and the spectrum of liver histopathology underlying MASLD and MASH in human populations remains incompletely explored. This is a critical knowledge gap since metal levels in body fluids or extrahepatic tissue may not reflect that of the liver tissue [2, 10, 56]. Currently, few studies have quantitatively explored the associations between biopsy-based hepatic levels of certain metals and non-cancerous liver perturbations in humans, which are largely limited by small sample size, targeted measurements of specific metals, narrow focus on high-exposure contexts, etc. [56, 59, 60]. This is at least in part attributed to the limited access to human liver biopsy samples.

Formalin-fixed paraffin-embedded (FFPE) human tissue biopsies are the most commonly available samples for retrospective studies. However, whether the metal levels as well as their interindividual variability are preserved during sample fixation and preparation remains unclear. The few studies published thus far focusing on comparing quantitative metal data between paired fresh/frozen and FFPE liver tissue samples are limited by being non-human study, small sample size, few metals, etc. [61–70].

We aim in this study to compare levels of 25 metals and trace elements and examine the preservation of their inter-individual variability between paired frozen and FFPE human liver tissues. Our goal is to assess which metals and elements are suitable for toxicological, biochemical or nutritional analysis in human FFPE samples.

Results

In the present study, we quantified the levels of 25 metals and trace elements within paired frozen and FFPE human liver tissues. Our frozen human non-cancerous liver tissues were procured during autopsy or biopsy and were sent to one of the two tissue banks from which we received the tissues (the Cooperative Human Tissue Network (CHTN) or National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders). Demographic information is presented in the methods section and supplementary tables (supplementary Table S1). We present the overall distributions, statistical differences, and correlations between the paired tissues in the subsections below.

Distribution of Metal Content

The content of 25 metals from 30 unique non-cancerous liver tissue samples (each with a paired FFPE and fresh frozen sample) were quantified. Among all metals, 17 are detectable in all samples. Among all frozen tissues, only one metal (Uranium, U) was non-detectable in more than 10 samples. For FFPE samples, more metals had non-detectable levels in over 10 samples (beryllium, Be; thorium, Th; and thallium, Tl). In general, many metals demonstrated considerable level of inter-individual variability in frozen tissues. Some extreme examples include lead (Pb), arsenic (As), chromium (Cr), and copper (Cu) (coefficient of variation or CV>200%) (Table 1). Notably, both previously established hepatoprotective metals e.g. selenium (Se) and zinc (Zn) as well as hepatotoxic metals such as Cd and Pb are all detectable among both frozen and FFPE samples with inter-individual difference in their content ranging from several to a few thousand folds (Table 1). Boxplots of the data are presented in Figure S1.

Table 1:

Descriptive statistics (mean (Mn), median (Md), standard deviation (SD), minimum (Min.), first quartile (1st Qu), third quartile (3rd Qu.), maximum (Max.), skewness, kurtosis, and coefficient of variation (CV) of the 25 metals quantified across the frozen and FFPE samples utilized in this study. Number of zeroes (No. of zeroes) denotes how many samples for the respective type (frozen or FFPE) and metal were below quantifiable levels via ICP-MS.

Metal Method No. of Zeros (n) Mn Md SD Min 1st Qu. 3rd Qu. Max Skewness Kurtosis CV (%)
Ag Frozen 0 0.01 0.00 0.01 0.00 0.00 0.01 0.03 3.02 13.40 112.84
FFPE 0 0.03 0.03 0.01 0.01 0.02 0.04 0.06 0.40 2.29 44.70
Al Frozen 0 0.91 0.60 1.50 0.12 0.42 0.81 8.66 4.82 25.47 164.41
FFPE 0 17.27 14.08 7.98 6.40 11.97 21.47 42.08 1.26 4.60 46.22
As Frozen 0 0.01 0.00 0.03 0.00 0.00 0.01 0.15 4.94 26.20 254.39
FFPE 10 0.02 0.02 0.02 0.00 0.00 0.03 0.08 0.94 2.70 106.93
Ba Frozen 0 0.03 0.02 0.02 0.00 0.01 0.04 0.08 0.77 2.36 88.69
FFPE 0 0.55 0.49 0.32 0.07 0.33 0.63 1.53 1.37 4.83 58.34
Be Frozen 7 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.97 8.94 95.34
FFPE 12 0.04 0.02 0.05 0.00 0.00 0.06 0.21 1.82 6.92 129.13
Ca Frozen 0 50.29 44.75 23.25 20.16 32.13 61.20 120.19 1.33 4.73 46.22
FFPE 0 626.13 386.79 435.91 216.48 316.49 769.02 2020.37 1.44 4.70 69.62
Cd Frozen 0 1.10 0.90 0.95 0.00 0.42 1.49 4.08 1.18 4.30 86.98
FFPE 0 1.41 1.12 1.26 0.05 0.52 1.89 4.93 1.22 3.73 89.56
Co Frozen 0 0.04 0.04 0.02 0.00 0.03 0.05 0.09 −0.01 3.58 40.76
FFPE 0 0.05 0.05 0.02 0.01 0.04 0.06 0.11 0.38 2.52 43.50
Cr Frozen 0 0.11 0.03 0.25 0.01 0.02 0.09 1.28 3.77 17.52 218.81
FFPE 0 1.22 0.87 1.32 0.26 0.58 1.07 6.26 2.83 10.50 108.24
Cu Frozen 0 11.55 6.30 24.50 1.17 4.75 9.71 139.86 5.03 26.86 212.15
FFPE 0 53.10 16.88 78.65 8.91 12.56 26.41 266.07 1.76 4.51 148.14
Fe Frozen 0 197.02 144.81 159.54 22.65 72.79 250.52 597.93 1.12 3.26 80.97
FFPE 0 292.17 208.38 274.14 46.71 120.77 329.03 1142.86 1.92 6.05 93.83
K Frozen 0 2353.23 2376.75 579.18 890.58 2102.51 2828.47 3257.18 −0.70 2.85 24.61
FFPE 4 38.95 30.09 40.03 0.00 13.84 42.61 163.48 1.94 6.70 102.78
Mg Frozen 0 156.51 159.26 39.10 60.55 141.82 181.19 224.55 −0.75 3.44 24.98
FFPE 0 143.31 134.22 80.43 35.58 80.67 211.31 309.83 0.41 2.00 56.13
Mn Frozen 0 1.41 1.34 0.61 0.23 1.07 1.82 2.53 −0.03 2.50 43.07
FFPE 0 1.70 1.51 0.89 0.50 1.09 2.12 4.42 1.43 5.07 52.27
Mo Frozen 0 0.68 0.63 0.36 0.04 0.47 0.94 1.41 0.31 2.30 53.29
FFPE 0 1.01 0.89 0.68 0.28 0.64 1.13 3.32 1.84 6.36 67.33
Na Frozen 0 1198.02 1176.65 406.35 561.25 930.85 1406.05 2071.61 0.53 2.49 33.92
FFPE 0 456.04 375.51 376.94 36.38 101.13 764.99 1234.12 0.48 1.95 82.66
Ni Frozen 0 0.03 0.01 0.06 0.00 0.01 0.02 0.30 3.72 16.70 196.15
FFPE 0 8.63 0.54 38.00 0.08 0.14 0.96 207.78 5.05 26.92 440.49
Pb Frozen 0 0.07 0.02 0.22 0.00 0.01 0.05 1.25 5.07 27.16 304.58
FFPE 0 0.38 0.13 0.69 0.05 0.10 0.25 2.87 2.81 9.47 182.84
Sb Frozen 0 0.00 0.00 0.00 0.00 0.00 0.00 0.02 3.22 13.45 119.49
FFPE 1 0.03 0.02 0.04 0.00 0.02 0.04 0.23 3.85 19.04 125.28
Se Frozen 0 0.56 0.52 0.24 0.16 0.41 0.72 1.25 0.74 3.51 43.18
FFPE 0 1.31 1.16 0.65 0.48 0.90 1.46 2.99 1.18 3.84 49.77
Th Frozen 9 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.27 15.12 151.70
FFPE 21 0.01 0.00 0.01 0.00 0.00 0.01 0.05 2.47 8.37 209.73
Tl Frozen 2 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.07 12.08 154.21
FFPE 28 0.00 0.00 0.00 0.00 0.00 0.00 0.01 3.72 15.41 388.83
U Frozen 18 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.68 5.79 151.49
FFPE 5 0.01 0.01 0.00 0.00 0.01 0.01 0.02 −0.14 2.68 59.33
V Frozen 0 0.01 0.00 0.01 0.00 0.00 0.01 0.05 3.15 13.27 166.92
FFPE 6 0.02 0.02 0.02 0.00 0.01 0.02 0.08 1.57 5.47 98.15
Zn Frozen 0 62.04 54.81 29.19 12.73 47.01 73.83 148.57 1.03 4.48 47.05
FFPE 0 90.43 81.30 49.48 33.32 55.05 112.66 244.68 1.57 5.45 54.72

Relationship between metal data and demographic data (age, race and sex) was assessed only in frozen samples as frozen tissues provides a “gold standard” representative metal content (Table S2). When comparing between “White/Caucasian” and “Non-White” races, only manganese (Mn), showed significant difference between the two groups (nominal, unadjusted p = 0.03). When comparing between biologically female or male samples there were no statistically significant differences between the two biological sexes. The correlation between metals and age was assessed with Kendall’s Tau, no metals showed correlation (Table S2).

Paired sign test demonstrated that the metal data generally shows a significantly higher level among the FFPE sample compared to their paired frozen sample. This is evident by the statistical significance (p < 0.05) for most metals (Table 2). The only metals without a significant difference between the frozen and FFPE concentrations are beryllium (Be), Mg, manganese (Mn), cobalt (Co), and thallium (Tl). Overall, we find that FFPE preservation changes the absolute tissue content of metals.

Table 2:

Results of paired sign test comparing the FFPE samples to their respective frozen sample to examine if there is a significant change in metal levels after FFPE preservation. If a sample was below quantifiable levels for either the frozen or FFPE sample, it was removed from the analysis. If pairs were removed, then the n value in the n pairs column is less than 30. Significance (yes vs. no) is determined based on a p value less than 0.05, without adjustment for multiple comparisons.

Metal Number of pairs Sign test statistic value Sign test p value
Be 9 1.13 0.26
Na 30 −4.02 <0.001
Mg 30 −1.46 0.14
Al 30 5.48 <0.001
K 24 −5.48 <0.001
Ca 30 5.48 <0.001
V 24 2.56 0.01
Cr 30 5.11 <0.001
Mn 30 1.10 0.27
Fe 30 3.29 <0.001
Co 30 1.83 0.07
Ni 30 5.11 <0.001
Cu 30 5.11 <0.001
Zn 30 4.75 0.00
As 19 2.19 0.03
Se 29 4.75 <0.001
Mo 30 2.19 0.03
Ag 30 5.48 <0.001
Cd 30 3.65 <0.001
Sb 29 5.11 <0.001
Ba 30 5.48 <0.001
Tl 2 −4.54 <0.001
Pb 30 5.48 <0.001
Th 9 −0.85 0.39
U 8 4.27 <0.001

Correlation Metrics between Frozen and FFPE Preservations

To explore whether the interindividual variability of the metal levels is preserved after FFPE preparation, we conducted correlation analysis in the metal levels between frozen and their paired FFPE samples. Table 3 shows correlation metric estimates based on the collected data and the 95% confidence interval (CI) resulting from the parametric bootstrap. Zn, Cd, and Fe had the three strongest estimates for each of the correlation measures, with Kendall’s Tau as 0.69, 0.82, and 0.67, respectively. Se had a moderate correlation between frozen and FFPE concentrations (Kendall’s Tau = 0.42). To assess whether there is a linear relationship in the metal levels between the two fixations for these four metals, we also assessed the Pearson correlation. These four metals (Zn, Cd, Fe, and Se) demonstrated strong Pearson correlation in their levels between frozen and FFPE samples, with a coefficient of 0.93, 0.93, 0.90, and 0.74, respectively. Results for these four metals are visualized in Figure 1. Summary forest plots for Kendall’s Tau and Pearson correlation are in supplement Figure S2. Individual plots for all metals can be found in the supplement Figure S3.

Table 3:

Correlation statistics for each metal between the frozen and FFPE samples from Kendall’s Tau and Pearson Correlation tests. For each test, the estimated (Est.) correlation value, 95% confidence interval (CI), width, and p value are presented. Metals with 10 or more below quantifiable level concentrations were removed from the analysis.

Metal Kendall's Tau Est. Kendall's Tau 95% CI Kendall's Tau Width Pearson Est. Pearson 95% CI Pearson Width
Ag 0.2 (−0.09, 0.45) 0.54 0.27 (−0.08, 0.50) 0.57
Al 0.16 (−0.15, 0.44) 0.59 0.56 (−0.25, 0.90) 1.14
Ba −0.01 (−0.31, 0.27) 0.58 0.06 (−0.32, 0.58) 0.9
Ca 0.16 (−0.04, 0.35) 0.39 0.18 (−0.06, 0.37) 0.43
Cd 0.82 (0.70, 0.90) 0.2 0.93 (0.83, 0.97) 0.14
Co 0.18 (−0.15, 0.48) 0.63 0.15 (−0.32, 0.60) 0.92
Cr 0.16 (−0.14, 0.40) 0.54 −0.05 (−0.21, 0.13) 0.34
Cu 0.15 (−0.15, 0.39) 0.54 0.29 (−0.23, 0.86) 1.09
Fe 0.67 (0.50, 0.81) 0.31 0.9 (0.73, 0.95) 0.22
K 0.06 (−0.23, 0.36) 0.59 −0.26 (−0.71, 0.21) 0.91
Mg 0.28 (0.05, 0.50) 0.44 0.45 (0.16, 0.67) 0.51
Mn 0.4 (0.21, 0.52) 0.31 0.47 (0.23, 0.63) 0.4
Mo 0.34 (0.07, 0.56) 0.49 0.47 (0.16, 0.71) 0.55
Na 0.07 (−0.17, 0.27) 0.44 0.1 (−0.21, 0.38) 0.6
Ni 0.09 (−0.22, 0.38) 0.6 −0.03 (−0.18, 0.40) 0.58
Pb 0.26 (0.01, 0.47) 0.46 0.68 (−0.05, 1.00) 1.05
Sb 0.06 (−0.21, 0.34) 0.54 0.07 (−0.23, 0.48) 0.71
Se 0.42 (0.11, 0.64) 0.53 0.74 (0.47, 0.88) 0.41
V 0.08 (−0.19, 0.36) 0.55 0.32 (−0.19, 0.71) 0.9
Zn 0.69 (0.50, 0.83) 0.33 0.93 (0.83, 0.97) 0.14

Figure 1:

Figure 1:

Correlation plots of the 4 metals (a. Cd, b. Fe, c. Se, and d. Zn) with the strongest Pearson correlations (in alphabetical order). 95% confidence interval is shaded in grey. X and Y axes unites are in ng/mm3 for the respective preservation method.

Discussion:

In this study, we aimed to investigate the relationship of quantity of metals in human liver tissues between paired frozen and FFPE preservation procedures. Our primary goal is to identify which metals among FFPE liver tissue still preserve their levels and/or inter-individual variability as they are in frozen format. Our data suggest that Zn, Cd, Fe, and possibly Se are suitable for large-scale association studies on various liver disease among human populations by leveraging the broadly archived FFPE liver biopsies. As an exploratory pilot study, these results should be primarily utilized for hypothesis-generation and not confirmation as we did not perform power analysis or adjustment for multiple comparisons.

Our analysis revealed that concentrations (ng/mm3 tissue) of the FFPE samples tended to be greater than those of the frozen samples for most metals. We hypothesize that this is due to the shrinkage of tissue during the fixation process. Importantly, our study shows the level of four metals (Zn, Cd, Fe, and Se) were moderately to strongly correlated between frozen and FFPE samples. The reason underlying this high correlation in the level of these metals between the paired samples could be due to their chemical and biochemical properties. Chemically, these all have a charge of 2+ (Fe is sometimes present as 3+). Both Zn and Cd are known to bind metallothionein proteins [71]. Zn is an antioxidant involved in various antioxidative and detoxification processes within the liver. There are over 3,000 proteins in which zinc is incorporated across various protein classes [72, 73] which could provide as protection from washout during preservation. Cd is a toxic heavy metal that is known to cause toxicity by replacing Zn and Se in their respective processes, especially selenoproteins and metalloproteins [74, 75]. This binding is generally irreversible, and the half-life of Cd is generally decades long, leading to chronic issues within the liver [74, 75]. Fe is generally stored in the liver, primarily through ferritin [76–78]. Therefore, the complex binding with various proteins could be the primary reason leading to minimal leaching during the FFPE preservation process.

Pb and Al had strong Pearson correlation (coefficient = 0.68 and 0.56, respectively) between the frozen and FFPE samples. However, under the Kendall correlation analysis this relationship is no longer significant (Kendall’s Tau = 0.26, and 0.16, respectively), suggesting a poor concordance in general between the two tissue preparations. Upon analysis of the correlation plots (Figure S3) we find that the moderate Pearson correlation, but weak Kendall’s Tau is likely due to outlier and clustering of the concentration values. For aluminum, the frozen values have a narrower range than the FFPE concentrations. Meanwhile, in Pb, most of the concentrations have a low value in both frozen and FFPE, but potential outliers are skewing the linear correlation. It is likely that with a larger sample size these two metals can be cautiously studied with certain corrections and larger sample sizes.

There are several limitations in our study. One potential problem of our study is the normalization method. Since we were unable to dry tissues prior to digestion for ICP-MS as done in previous comparative analyses, we had to normalize the tissues utilizing other methods [65, 70]. The frozen tissues were easy to weigh given the larger size. However, deparaffinized FFPE tissues are miniscule, and an extremely sensitive scale was not available. Thus, we utilized computational methods to estimate the volume of the FFPE tissues and then estimated weight by published normal liver density (1 kg/L) [79–82]. However, it is also known that livers with increased fat content have slightly decreased densities (down to 0.90 kg/L) while livers with fibrosis have slightly increased densities (up to 1.10 kg/L). This may have slightly skewed our weight estimates. While our FFPE tissues were imaged and thus we could utilize computational methods to estimate the appropriate density, this has not been done previously and the estimates on how to adjust the density are debatable. Due to this, the normal liver density in the literature was utilized for normalization, which could lead to errors in estimating the metal content in FFPE samples.

Second, although our sample size is bigger than most published similar studies as summarized in Introduction, to thoroughly conclude which metals have a strong relationship between preservation methods, a larger sample size would still be required. In addition, it may not be valid to simply assume that the correlation of the metal levels among the paired samples is linear, and thus the Kendall’s Tau results are more appropriate.

In this study, we found that out of the 25 metals analyzed, most of the metals are detectable among the majority of samples regardless of preservation type (frozen vs FFPE). Metal levels tend to show significant differences after FFPE preservation in comparison to the original flash frozen tissues. We found that Zn, Cd, and Fe present strong linear relationships between frozen and FFPE tissue and can be utilized for future correlative studies utilizing archived liver tissues. Se, a hepatoprotective element, may also be considered for future correlative studies as it had moderate Pearson correlation and moderate Kendall’s Tau. Al, and Pb need to be investigated in larger datasets to assess the nature of the relationship as they presented with high linear correlation but weak rank-based correlation. Overall, this study indicates that while many metals are not consistent within liver tissues after the formalin-fixed and paraffin-embedding process, some metals show strong enough linear relationships to be investigated by ICP-MS.

Materials and Methods

Sample Collection

Frozen non-cancerous liver tissues were either from surgical biopsies or autopsies from the Cooperative Human Tissue Network (CHTN) or National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders. All samples were de-identified prior to receipt. Both original sample collection (IRB 2018–42) and the current study (IRB-24-04-6777) using these samples were approved by the Institutional Review Board (IRB) of the Wayne State University. The demographics are presented in Table S1.

Fresh vs. Formalin Fixation

Randomly chosen samples were cut with a carbon blade (Electron Microscopy Sciences, Cat# 71964, Hatfield, PA, USA) to prevent metal contamination. All samples were cut on the same day utilizing a new blade. One piece of tissue was weighed and placed in a 1.7 mL Eppendorf tube and kept in −80 until shipping to Dr. Cai’s lab at the University of Louisville (Louisville, KY, USA) under dry ice. An adjacent piece of tissue was cut and placed in a cassette for formalin fixation. Immediately after being placed on the cassette, the samples were placed in 10% formalin for fixation. After 24 hours, tissues were placed in ethanol for 12 hours. Tissues were subsequently processed utilizing the Tissue Tek VIP (Miles Scientific, Newark, DE, USA) and embedded in paraffin. FFPE tissue blocks were stored at room temperature until sectioning. 10 μM sections of tissue were deparaffinized and imaged prior to placing in a 1.7 mL Eppendorf tube. Frozen and FFPE tissues were digested and metals were quantified by using Inductively Coupled Plasma Quadrupole Mass Spectrometer (ICP-MS) at Dr. Cai’s lab (See below). The purpose of imaging the tissue section is to calculate the tissue volume for normalization of metals. The imaging was conducted by scanning each section in the Odyssey M (Licor, Lincoln, NE, USA) utilizing the slide image setting. Five samples were randomly chosen to be duplicated under this procedure for both frozen and FFPE tissues.

Tissue Digestion

Liver samples (15–70 mg) and deparaffinized sections as prepared above were placed in 1.7 mL Eppendorf tubes and digested with addition of 500 μl 70% nitric acid (Fisher Scientific trace metal grade, Cat# A509P500, Waltham, MA, USA). To ensure efficient digestion (until solution becomes clear without residues), the samples containing nitric acid were gently shacked at 65°C for 4 hours. Then the samples were diluted with 6.5 ml deionized water (Thermo Fisher Scientific, GenPure Pro, Waltham, MA, USA) into final 5% acid sample solutions for ICP-MS assay. Three reagent samples for blank controls were also similarly treated at the same time with tissues.

Tissue Sample ICP-MS Analysis

To measure the metal content in tissue samples with ICP-MS, the Agilent 7800 ICP-MS (Agilent Technologies, Japan) was optimized by performance check with 1ppb tuning solution. The assay program was auto tuned by 10 ppb tuning solution (Agilent Cat#5188–6564, Santa Clara, CA, USA). Sample solutions were introduced automatically by the SPS 4 auto-sampler. Twenty-five metals calibration standard, purchased from Inorganic Ventures (Cat# IV-STOCK-50, Christianburg, VA, USA), were included with serial metal standard dilutions in the same acid matrix of samples. Internal standard was purchased from Agilent (Cat#5188–6525, Santa Clara, CA, USA) and lithium (Li), scandium (Sc), germanium (Ge), rhodium (Rh), indium (In), terbium (Tb), and bismuth (Bi) were using as internal standard for metal recovery rate. Assay program was run by Agilent MassHunter software with He mode and each sample was read 3 times for final mean value. Standard solutions with 20ng/ml (trace metals) and 2000 ng/ml (sodium (Na), potassium (K), calcium (Ca), magnesium (Mg), and iron (Fe)) were used for quality control. Detailed parameters for ICP-MS setup are included in Table S3.

Data Preparation and Calculation of Metal Concentration

Metal concentrations were multiplied by the respective assay volume to find the total amount of metal in each sample. This total amount was then divided by the sample’s volume to have a normalized value of ng/mm3. Prior to ICP-MS analysis, FFPE samples were imaged on Odyssey M (Licor, Lincoln, NE, USA) utilizing the slide image setting then scales were added from the software of the instrument. The images were then taken to ImageJ [83, 84] for area quantification. All sections were cut at 10-micron thickness, and this was utilized to obtain the estimated volume of sections. For frozen tissues, since volume was not easily measured without potential contamination, a normalization factor of 1 kg/L was utilized. This value comes from the density measured in various studies [79–82].

Statistical Analysis

Metals with at least 10 (33%) samples with nondetectable frozen or FFPE concentrations were excluded from the correlation analysis. Analysis was performed in R utilizing base functions and dplyr package for data manipulation for both raw and natural log transformed data. Normality was assessed visually and with Shapiro-Wilk tests. Based on these assessments, we concluded that most metals were not normally distributed and opted to use non-parametric analysis methods. Therefore, non-parametric analyses based on non-transformed raw values were primarily applied to the subsequent analyses.

Associations between metal data (frozen samples only) and demographics [age, sex, race (white vs non-white)] were performed using Kendall’s Tau correlation (Age) and Mann-Whitney U test (sex and race). Comparison of metal concentrations between FFPE and frozen samples was conducted with paired Sign test. Samples with paired measurements in both sample types were included for analysis. To assess the correlation in the metal levels between the FFPE and frozen samples, Kendall rank correlation coefficient (Tau) was estimated. However, given the major goal of this study is to assess whether there is a linear relationship in the metal levels between the frozen and paired FFPE samples, we also conducted Pearson correlation using log transformed data. To quantify the uncertainty in these measures, we present each estimate with an associated 95% confidence interval (CI), calculated using Bias-Corrected and Accelerated (BCa) bootstrap methodology utilizing the confintr R package[85]. Given that the correlation is between paired samples, no additional adjustment for co-variables e.g. demographic data was applied. For all statistical tests, significance of statistics was defined as p<0.05. Due to this being an exploratory pilot study, we did not adjust for multiple comparisons. Analysis is performed in R (R Core Team, 2024).

Supplementary Material

Supplementary Files

This is a list of supplementary files associated with this preprint. Click to download.

Funding:

This study is supported in part by the NIEHS grant (R01ES034410, to W.L. & A.C.), and the University of Louisville Center for Integrative Environmental Health Sciences (CIEHS), NIEHS grant (P30 ES030328, to L.C.). Nivisa Vakeesan is supported by the NIH/NIEHS PIGE T32 (T32ES036169).

Funding Statement

This study is supported in part by the NIEHS grant (R01ES034410, to W.L. & A.C.), and the University of Louisville Center for Integrative Environmental Health Sciences (CIEHS), NIEHS grant (P30 ES030328, to L.C.). Nivisa Vakeesan is supported by the NIH/NIEHS PIGE T32 (T32ES036169).

Footnotes

Institutional Review Board Statement: All samples were de-identified prior to receipt. The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Wayne State University (protocol code IRB 2018–42, date of approval; IRB-24-04-6777, date of approval).

Informed Consent Statement: All samples were de-identified prior to receipt.

Competing Interests: The authors do not declare any competing interests.

References:

  • 1.Adetunji A.G. and Obeng-Gyasi E., Investigating the Interplay of Toxic Metals and Essential Elements in Liver Disease. International Journal of Environmental Research and Public Health, 2024. 21(6): p. 762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Baj J., et al. , Assessment of the Concentration of 51 Elements in the Liver and in Various Parts of the Human Brain-Profiling of the Mineral Status. Nutrients, 2023. 15(12). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bravo M., et al. , Magnesium and Liver Metabolism Through the Lifespan. Adv Nutr, 2023. 14(4): p. 739–751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Guan D.-X., Yang C., and Nriagu J.O., Editorial: The role of essential trace elements in health and disease. Frontiers in Public Health, 2024. Volume 11 - 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Han X., et al. , Effects of multiple metals exposure on abnormal liver function: The mediating role of low-density lipoprotein cholesterol. Ecotoxicology and Environmental Safety, 2024. 276: p. 116283. [DOI] [PubMed] [Google Scholar]
  • 6.Jomova K., et al. , Essential metals in health and disease. Chemico-Biological Interactions, 2022. 367: p. 110173. [DOI] [PubMed] [Google Scholar]
  • 7.Jomova K., et al. , Essential metals in health and disease. Chem Biol Interact, 2022. 367: p. 110173. [DOI] [PubMed] [Google Scholar]
  • 8.Kumar R., et al. , Metals in the human liver: An underappreciated risk factor of hepatic insulin resistance and associated pathophysiology. Environ Pollut, 2025. 383: p. 126844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kumar R., et al. , Metals in the human liver: An underappreciated risk factor of hepatic insulin resistance and associated pathophysiology. Environmental Pollution, 2025. 383: p. 126844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Li Q., et al. , The preferential accumulation of heavy metals in different tissues following frequent respiratory exposure to PM2.5 in rats. Scientific Reports, 2015. 5(1): p. 16936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Li Y., et al. , Associations of multiple toxic metal exposures with metabolic dysfunction-associated fatty liver disease: NHANES 2011–2018. Frontiers in Nutrition, 2023. Volume 10 - 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ma C., et al. , Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases. Biochemical Pharmacology, 2022. 205: p. 115242. [DOI] [PubMed] [Google Scholar]
  • 13.Tang S., et al. , Association between blood heavy metal exposure levels and risk of metabolic dysfunction associated fatty liver disease in adults: 2015–2020 NHANES large cross-sectional study. Frontiers in Public Health, 2024. Volume 12 - 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Teschke R., Aluminum, Arsenic, Beryllium, Cadmium, Chromium, Cobalt, Copper, Iron, Lead, Mercury, Molybdenum, Nickel, Platinum, Thallium, Titanium, Vanadium, and Zinc: Molecular Aspects in Experimental Liver Injury. International Journal of Molecular Sciences, 2022. 23(20): p. 12213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Xie Z., et al. , Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003–2018. Frontiers in Public Health, 2023. Volume 11 - 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Yang Z., et al. , Heavy metals exposure is associated with early liver dysfunction among rural residents aged 40–75 years in southwest China. Journal of Applied Toxicology, 2022. 42(6): p. 1044–1056. [DOI] [PubMed] [Google Scholar]
  • 17.Zhu Q., et al. , Toxic and essential metals: metabolic interactions with the gut microbiota and health implications. Frontiers in Nutrition, 2024. Volume 11 - 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Targher G., Valenti L., and Byrne Christopher D., Metabolic Dysfunction–Associated Steatotic Liver Disease. New England Journal of Medicine, 2025. 393(7): p. 683–698. [DOI] [PubMed] [Google Scholar]
  • 19.Takahashi Y. and Fukusato T., Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World Journal of Gastroenterology, 2014. 20(42): p. 15539–15548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Brown G.T. and Kleiner D.E., Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism, 2016. 65(8): p. 1080–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Brunt E.M. and Tiniakos D.G., Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol, 2010. 16(42): p. 5286–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Leow W.-Q., et al. , Non-alcoholic fatty liver disease: the pathologist’s perspective. CMH, 2023. 29(Suppl): p. S302–S318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yu J., et al. , The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. Gastroenterology Research and Practice, 2016. 2016(1): p. 2862173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kounatidis D., et al. , NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics. Biomedicines, 2024. 12(4): p. 826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hao L. and Chai Z., Nonalcoholic fatty liver disease: pathogenesis and intervention. Precision Nutrition, 2023. 2(1): p. e00029. [Google Scholar]
  • 26.Grander C., Grabherr F., and Tilg H., Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovascular Research, 2023. 119(9): p. 1787–1798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Banini B.A. and Sanyal A.J., Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clin Med Insights Ther, 2016. 8: p. 75–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Pierantonelli I. and Svegliati-Baroni G., Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. Transplantation, 2019. 103(1): p. e1–e13. [DOI] [PubMed] [Google Scholar]
  • 29.Pafili K. and Roden M., Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab, 2021. 50: p. 101122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pafili K. and Roden M., Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Molecular Metabolism, 2021. 50: p. 101122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Li X. and Wang H., Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease. Cell & Bioscience, 2020. 10(1): p. 140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kupčová V., et al. , Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health, 2019. 16(19): p. 3570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hardy T., et al. , Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. Annual Review of Pathology: Mechanisms of Disease, 2016. 11(Volume 11, 2016): p. 451–496. [DOI] [PubMed] [Google Scholar]
  • 34.Makri E., Goulas A., and Polyzos S.A., Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Archives of Medical Research, 2021. 52(1): p. 25–37. [DOI] [PubMed] [Google Scholar]
  • 35.Machado M.V. and Diehl A.M., Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology, 2016. 150(8): p. 1769–1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Loomba R., Friedman S.L., and Shulman G.I., Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell, 2021. 184(10): p. 2537–2564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Dowman J.K., Tomlinson J.W., and Newsome P.N., Pathogenesis of non-alcoholic fatty liver disease. QJM: An International Journal of Medicine, 2009. 103(2): p. 71–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Arab J.P., Arrese M., and Trauner M., Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. Annual Review of Pathology: Mechanisms of Disease, 2018. 13(Volume 13, 2018): p. 321–350. [DOI] [PubMed] [Google Scholar]
  • 39.Buzzetti E., Pinzani M., and Tsochatzis E.A., The multiple-hit pathogenesis of nonalcoholic fatty liver disease (NAFLD). Metabolism, 2016. 65(8): p. 1038–1048. [DOI] [PubMed] [Google Scholar]
  • 40.Zhang L., et al. , Bioinformatic Analysis for Exploring Target Genes and Molecular Mechanisms of Cadmium-Induced Nonalcoholic Fatty Liver Disease and Targeted Drug Prediction. J Appl Toxicol, 2025. 45(5): p. 858–865. [DOI] [PubMed] [Google Scholar]
  • 41.Xu C., et al. , Association of blood cadmium levels with all-cause and cause-specific mortality among adults with non-alcoholic fatty liver disease: a prospective cohort study. Front Public Health, 2025. 13: p. 1573760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sun J., et al. , Cadmium promotes nonalcoholic fatty liver disease by inhibiting intercellular mitochondrial transfer. Cell Mol Biol Lett, 2023. 28(1): p. 87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Spaur M., et al. , Association of blood manganese, selenium with steatosis, fibrosis in the National Health and Nutrition Examination Survey, 2017–18. Environ Res, 2022. 213: p. 113647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Shi X., et al. , Associations of non-essential metals and their mixture with non-alcoholic fatty liver disease in Chinese older adults. Environ Geochem Health, 2025. 47(6): p. 228. [DOI] [PubMed] [Google Scholar]
  • 45.Park E., et al. , Association between environmental exposure to cadmium and risk of suspected non-alcoholic fatty liver disease. Chemosphere, 2021. 266: p. 128947. [DOI] [PubMed] [Google Scholar]
  • 46.Ogundipe E. and Obeng-Gyasi E., Combined Effects of Environmental and Lifestyle Exposures on Liver Health: The Mediating Role of Allostatic Load. Toxics, 2025. 13(11). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Niture S., et al. , Cadmium modulates steatosis, fibrosis, and oncogenic signaling in liver cancer cells by activating notch and AKT/mTOR pathways. Environ Toxicol, 2023. 38(4): p. 783–797. [DOI] [PubMed] [Google Scholar]
  • 48.Nguyen H.D. and Kim M.S., Cadmium, lead, and mercury mixtures interact with non-alcoholic fatty liver diseases. Environ Pollut, 2022. 309: p. 119780. [DOI] [PubMed] [Google Scholar]
  • 49.Li Y., et al. , Associations of multiple toxic metal exposures with metabolic dysfunction-associated fatty liver disease: NHANES 2011–2018. Front Nutr, 2023. 10: p. 1301319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Li Y., et al. , Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife. Dig Dis Sci, 2022. 67(2): p. 689–696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Li C., et al. , Environmental Cadmium Exposure Exacerbated Bone Loss in NAFLD Mice. Biol Trace Elem Res, 2024. 202(10): p. 4586–4595. [DOI] [PubMed] [Google Scholar]
  • 52.Lee D.W., et al. , Association between heavy metal exposure and biomarkers for non-alcoholic fatty liver disease in Korean adolescents. Heliyon, 2024. 10(19): p. e37840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kim J.H., et al. , Blood Concentrations of Lead, Cadmium, and Mercury Are Associated With Alcohol-Related Liver Disease. J Korean Med Sci, 2023. 38(49): p. e412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Gong X., et al. , Unraveling cadmium-driven liver inflammation with a focus on arachidonic acid metabolites and TLR4/ IκBα /NF-κB pathway. Ecotoxicol Environ Saf, 2023. 286: p. 117177. [DOI] [PubMed] [Google Scholar]
  • 55.Chen H.N., et al. , Interactive and joint effects of toxic metals and oxidative balance score on the risk of mortality in adults with NAFLD. Ecotoxicol Environ Saf, 2025. 293: p. 117958. [DOI] [PubMed] [Google Scholar]
  • 56.Baj J., et al. , Linking Metallic Micronutrients and Toxic Xenobiotics to Atherosclerosis and Fatty Liver Disease-Postmortem ICP-MS Analysis of Selected Human Tissues. Nutrients, 2023. 15(15). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Adetunji A.G. and Obeng-Gyasi E., Investigating the Interplay of Toxic Metals and Essential Elements in Liver Disease. Int J Environ Res Public Health, 2024. 21(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kim D.-W., et al. , Association between Pb, Cd, and Hg Exposure and Liver Injury among Korean Adults. International Journal of Environmental Research and Public Health, 2021. 18(13): p. 6783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Sinan H., et al. , Differences of Accumulated Heavy Metal Levels in End-Stage Liver Disease, Wilson’s Disease, and Other Etiologies. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, 2021. 13(3): p. 184–193. [Google Scholar]
  • 60.Aggarwal M., et al. , S1121 Role of Markers of Heavy Metal Metabolism in Identification of Hepatic Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD). Official journal of the American College of Gastroenterology | ACG, 2020. 115: p. S564. [Google Scholar]
  • 61.Yamkate P., Gold R.M., and Xenoulis P.G., Assessment of Copper Accumulation in Archived Liver Specimens from Cats. Journal of Feline Medicine and Surgery, 2021. 23(6): p. 526–533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Wróbel P.M., et al. , Feasibility Study of Elemental Analysis of Large Population of Formalin Fixed Paraffin Embedded Tissue Samples. Spectrochimica Acta Part B: Atomic Spectroscopy, 2020. 173: p. 105971. [Google Scholar]
  • 63.Theron P.F., et al. , Causes of Variation of Copper, Iron, Manganese, Zinc and Magnesium Levels in Bovine Livers. Journal of the South African Veterinary Association, 1973. 44(3): p. 271–277. [PubMed] [Google Scholar]
  • 64.Nemolato S., et al. , Deparaffination Time: A Crucial Point in Histochemical Detection of Tissue Copper. European Journal of Histochemistry, 2008. 52(3): p. 175–178. [DOI] [PubMed] [Google Scholar]
  • 65.McCormack M.A., Jackson B.P., and Dutton J., Effects of Formalin Fixation on Trace Element Concentrations in Bottlenose Dolphin (Tursiops Truncatus) Tissues. Environmental Toxicology and Chemistry, 2020. 39(6): p. 1149–1164. [DOI] [PubMed] [Google Scholar]
  • 66.Koizumi N., Hatayama F., and Sumino K., Problems in the Analysis of Cadmium in Autopsied Tissues. Environmental Research, 1994. 64(2): p. 192–198. [DOI] [PubMed] [Google Scholar]
  • 67.Johnston A.N., et al. , Influence of Biopsy Specimen Size, Tissue Fixation, and Assay Variation on Copper, Iron, and Zinc Concentrations in Canine Livers. American Journal of Veterinary Research, 2009. 70(12): p. 1502–1511. [DOI] [PubMed] [Google Scholar]
  • 68.Gupta A. and Al-Dissi A., Correlation of Hepatic Copper Levels, Rhodanine Scores and Histological Diagnosis in Archived Canine Liver Samples. Canadian Journal of Veterinary Research, 2022. 86(4): p. 300–305. [PMC free article] [PubMed] [Google Scholar]
  • 69.Bush V.J., et al. , Essential and Toxic Element Concentrations in Fresh and Formalin-Fixed Human Autopsy Tissues. Clinical Chemistry, 1995. 41(2): p. 284–294. [PubMed] [Google Scholar]
  • 70.Bischoff K., et al. , The Effects of Formalin Fixation and Tissue Embedding of Bovine Liver on Copper, Iron, and Zinc Analysis. Journal of Veterinary Diagnostic Investigation, 2008. 20(2): p. 220–224. [DOI] [PubMed] [Google Scholar]
  • 71.Yang R., et al. , Metallothionein: A Comprehensive Review of Its Classification, Structure, Biological Functions, and Applications. Antioxidants (Basel), 2024. 13(7). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Maret W., Zinc Biochemistry: From a Single Zinc Enzyme to a Key Element of Life. Advances in Nutrition, 2013. 4(1): p. 82–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Chen B., et al. , Cellular Zinc Metabolism and Zinc Signaling: From Biological Functions to Diseases and Therapeutic Targets. Signal Transduction and Targeted Therapy, 2024. 9(1): p. 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Zhang C., et al. , Selenium Prevent Cadmium-Induced Hepatotoxicity Through Modulation of Endoplasmic Reticulum-Resident Selenoproteins and Attenuation of Endoplasmic Reticulum Stress. Environmental Pollution, 2020. 260: p. 113873. [DOI] [PubMed] [Google Scholar]
  • 75.Davidova S., Milushev V., and Satchanska G., The Mechanisms of Cadmium Toxicity in Living Organisms. Toxics, 2024. 12(12): p. 875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Rishi G. and Subramaniam V.N., The Liver in Regulation of Iron Homeostasis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2017. 313(3): p. G157–G165. [DOI] [PubMed] [Google Scholar]
  • 77.Bonkovsky H.L., Iron and the Liver. The American Journal of the Medical Sciences, 1991. 301(1): p. 32–43. [DOI] [PubMed] [Google Scholar]
  • 78.Anderson E.R. and Shah Y.M., Iron Homeostasis in the Liver. Comprehensive Physiology, 2013. 3(1): p. 315–330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Sonnemans L.J.P., Monshouwer R., and Klein W.M., Liver volumetry at post-mortem CT and liver weight at autopsy: a correlative study. Journal of Forensic Radiology and Imaging, 2014. 2(2): p. 105. [Google Scholar]
  • 80.Hagen F., et al. , Correlation Between Liver Volume and Liver Weight in a Cohort With Chronic Liver Disease: A Semiautomated CT-Volumetry Study. Quantitative Imaging in Medicine and Surgery, 2022. 12(1): p. 376–383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Goumard C., et al. , Is computed tomography volumetric assessment of the liver reliable in patients with cirrhosis? HPB, 2014. 16(2): p. 188–194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Chan S.C., et al. , Estimating Liver Weight of Adults by Body Weight and Gender. World Journal of Gastroenterology, 2006. 12(14): p. 2217–2222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Schneider C.A., Rasband W.S., and Eliceiri K.W., NIH Image to ImageJ: 25 Years of Image Analysis. Nature Methods, 2012. 9(7): p. 671–675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Rasband W.S., ImageJ. 1997.
  • 85.Mayer M., confintr:Confidence Intervals. 2023.

Articles from Research Square are provided here courtesy of American Journal Experts

RESOURCES